文献速递乳腺技术与安全CTPET

乳腺癌放疗中形变配准评估临床受累淋巴结

Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.
PubMed 文献 · Br J Radiol · 2022-01-31

本研究回顾性纳入31例接受新辅助化疗后放疗的乳腺癌患者,通过形变融合PET-CT与计划CT评估RTOG乳腺勾画指南对化疗前阳性淋巴结的覆盖情况。结果显示142枚影像学阳性淋巴结中70%位于I区腋窝,仅71.1%(101枚)被完全覆盖,22.5%(32枚)部分覆盖,6.4%(9枚)完全未覆盖。作者认为RTOG图谱的局部淋巴结区域范围可能不足以充分覆盖阳性淋巴结,PET-CT图像融合可能有助于确保阳性淋巴结位于治疗体积内。

要点

  • RTOG乳腺图谱勾画的淋巴CTV仅完全覆盖71.1%的化疗前阳性淋巴结
  • 70%的阳性淋巴结位于I区腋窝,勾画时需重点评估该区域覆盖
  • 对新辅助化疗后淋巴结阳性患者,PET-CT形变融合可辅助确认阳性淋巴结纳入治疗体积

核心结论

  • RTOG图谱的局部淋巴结区域范围可能不足以充分覆盖阳性淋巴结。
  • 对新辅助化疗后淋巴结阳性患者,PET-CT图像融合可能有助于确保阳性淋巴结位于治疗体积内。

研究设计与样本

  • 回顾性评估2018年10月至2021年2月期间接受新辅助化疗后放疗的乳腺癌患者。
  • 共31例患者,142枚影像学定义的阳性淋巴结。
  • 将PET-CT图像导入计划软件,计划CT与PET-CT的CT图像先行刚性配准再行形变配准。
  • 在PET-CT数据集的CT成分上手动勾画阳性淋巴结,融合后转移至计划CT,评估按RTOG乳腺图谱预先勾画的淋巴CTV是否包含GTV-LN。

诊断标准与关键数值

  • 全组142枚淋巴结中,70%位于I区腋窝。
  • 仅71.1%(n=101)的淋巴结(涉及10例患者)被完全覆盖,22.5%(n=32)部分覆盖,6.4%(n=9)完全未覆盖。

临床应用与阅片要点

  • 作者认为RTOG图谱的局部淋巴结区域范围可能不足以充分覆盖阳性淋巴结。
  • 作者认为对新辅助化疗后淋巴结阳性患者,PET-CT图像融合可能有助于确保阳性淋巴结位于治疗体积内。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Modern radiotherapy (RT) techniques require careful delineation of the target. There is no particular RT contouring guideline for patients receiving neoadjuvant chemotherapy (NACT). In this study, we examined the distribution of pre-chemotherapy clinically positive nodal metastases.

METHODS: We explored the coverage rate of the RTOG breast contouring guideline by deformable fusion of 18-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) scan. We retrospectively evaluated neoadjuvant chemotherapy patients. All PET-CT images were imported into the planning software. We combined the planning CT and the CT images of PET-CT with rigid and then a deformable registration. We manually contoured positive lymph nodes on the CT component of the PET-CT data set and transferred them to planning CT after fusion. We evaluated whether previously contoured lymphatic CTVs, according to the RTOG breast atlas, include GTV-LNs.

RESULTS: All breast cancer patients between October 2018 and February 2021 were evaluated from the electronic database. There were 142 radiologically defined positive lymph nodes in 31 patients who were irradiated after NACT. Most LNs (70%) were in the level I axilla. Only 71.1% (n:101) of the whole lymph nodes in 10 patients were totally covered, 22.5% (n:32) partially covered and 6.4% %(n:9) totally undercovered.

CONCLUSIONS: The extent of regional nodal areas in the RTOG atlas may be insufficient to cover positive lymph nodes adequately. For patients with nodal involvement undergoing neoadjuvant chemotherapy, PET-CT image fusions can be helpful to be sure that positive lymph nodes are in the treatment volume.

ADVANCES IN KNOWLEDGE: RTOG contouring atlas may be insufficient to cover all involved lymph nodes after NACT. For patients with nodal involvement undergoing neoadjuvant chemotherapy, PET-CT image fusions may help to be sure that positive lymph nodes are in the treatment volume.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Turna, Rzazade, Canoğlu, et al. Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy. Br J Radiol. 2022. PMID: 35084214. doi:10.1259/bjr.20211234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。